Apollo Global Management (APO) Eyes DePuy Synthes While Adding $5.5 Billion In Auto Loans
Apollo Global Management (APO) is in advanced talks to acquire DePuy Synthes from Johnson & Johnson and plans to buy $5.5 billion in auto loans from Truist Financial. These deals aim to broaden Apollo's healthcare and consumer credit activities. Apollo has a market value of about $74.4 billion and focuses on credit, private equity, and real estate investments.
How this was made
The 30-second read
Why it matters
The announced transactions represent significant strategic shifts and could reshape Apollo's risk profile.
Market read
First‑time disclosure of sizable M&A and loan‑sale deals involving three major U.S. listed companies.
What to watch
Regulatory scrutiny of large private‑equity acquisitions in healthcare and the credit quality of the auto‑loan pool.
Background
Apollo Global Management is a diversified asset manager expanding into healthcare and consumer credit.
Ticker impact
Apollo Global Management is in advanced talks to acquire DePuy Synthes, a new potential M&A deal.
Possible upside if deal terms are favorable; risk of downside if integration concerns arise.
Large private equity transaction announced for the first time; market will price in acquisition premium and credit exposure.
Apollo plans to purchase $5.5 billion of auto loans from Truist Financial.
Modest positive impact on Truist's share price as the loan book is off‑loaded.
The transaction size is material and newly disclosed, influencing Truist's credit metrics.
Johnson & Johnson is the seller of DePuy Synthes in the proposed Apollo acquisition.
Potential modest upside as the carve‑out may improve earnings visibility.
Deal announcement is new; market will assess the impact of shedding a major medical‑device unit.
Market effects
Healthcare M&A activity may intensify; credit markets see increased loan‑sale activity.
U.S. financial and healthcare sectors could see valuation adjustments.
Large‑cap private equity moves attract global investor attention.
Counterpoint
Deal could be overvalued; integration risk may outweigh strategic benefits.
Key entities
- Asset ManagerApollo Global Management
Private equity and credit firm pursuing new acquisitions.
- Pharma/Medical DeviceJohnson & Johnson
Seller of DePuy Synthes.
- BankTruist Financial
Provider of the auto‑loan portfolio.



